Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
806.10
719.23
646.89
561.79
707.71
148.63
591.39
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
806.10
719.23
646.89
561.79
707.71
148.63
591.39
Raw Material Cost
220.63
216.17
223.76
183.08
197.66
101.59
153.55
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.68
5.76
5.26
4.63
3.94
2.93
2.40
Selling and Distribution Expenses
344.40
324.95
297.94
324.12
365.87
285.87
206.78
Other Expenses
3.01
3.45
2.96
0.50
0.94
0.31
1.06
Total Expenditure (Excl Depreciation)
600.81
581.36
556.56
516.80
576.85
393.52
373.28
Operating Profit (PBDIT) excl Other Income
205.3
137.89999999999998
90.3
45
130.9
-244.89999999999998
218.1
Other Income
1,054.13
-1.56
2.90
-61.37
21.39
-250.39
6.53
Operating Profit (PBDIT)
1,181.89
187.39
171.00
-6.17
202.11
-512.99
269.63
Interest
5.68
5.76
5.26
4.63
3.94
2.93
2.40
Exceptional Items
0.00
0.00
-0.40
0.40
0.07
0.00
-0.07
Gross Profit (PBDT)
585.47
503.06
423.13
378.71
510.05
47.04
437.84
Depreciation
0.00
77.77
77.77
53.87
53.87
48.65
48.65
Profit Before Tax
1,176.21
103.86
87.56
-64.27
144.37
-564.57
218.51
Tax
206.00
39.20
7.48
-50.90
19.07
-91.88
24.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
984.48
108.59
109.16
23.65
164.12
-445.17
214.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
984.48
108.59
109.16
23.65
164.12
-445.17
214.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.85
-7.04
-2.46
-1.34
-0.02
-0.02
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
979.63
101.55
106.70
22.31
164.09
-445.19
214.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,128.41
6,120.97
6,494.92
6,383.54
6,425.75
6,490.82
7,425.88
Earnings per share (EPS)
0.51
0.06
0.06
0.01
0.08
-0.22
0.11
Diluted Earnings per share
0.51
0.06
0.06
0.01
0.08
-0.22
0.11
Operating Profit Margin (Excl OI)
15.85%
15.46%
13.96%
0.24%
17.92%
-209.42%
36.26%
Gross Profit Margin
145.91%
25.25%
25.56%
-1.85%
28.01%
-347.13%
45.18%
PAT Margin
122.13%
15.1%
16.88%
4.21%
23.19%
-299.52%
36.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 12.08% vs 11.18% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 865.12% vs -4.87% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -32.38% vs 12.43% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -1.72% vs 9.43% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Tonghua Dongbao Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
806.10
0
806.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
806.10
0
806.10
Raw Material Cost
220.63
0
220.63
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.68
0
5.68
Selling and Distribution Expenses
344.40
0
344.40
Other Expenses
3.01
0.00
3.01
Total Expenditure (Excl Depreciation)
600.81
0
600.81
Operating Profit (PBDIT) excl Other Income
205.29
0.00
205.29
Other Income
1,054.13
0
1,054.13
Operating Profit (PBDIT)
1,181.89
0
1,181.89
Interest
5.68
0
5.68
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
585.47
0
585.47
Depreciation
0.00
0
0.00
Profit Before Tax
1,176.21
0
1,176.21
Tax
206.00
0
206.00
Provisions and contingencies
0
0
0.00
Profit After Tax
984.48
0
984.48
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
984.48
0
984.48
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.85
0
-4.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
979.63
0
979.63
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,128.41
0
7,128.41
Earnings per share (EPS)
0.51
0
0.51
Diluted Earnings per share
0.51
0
0.51
Operating Profit Margin (Excl OI)
15.85%
0%
0.00
15.85%
Gross Profit Margin
145.91%
0%
0.00
145.91%
PAT Margin
122.13%
0%
0.00
122.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.61 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 12.08% vs 11.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 13.90% vs -2.41% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 97.96 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 865.12% vs -4.87% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 496.95% vs -40.39% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.78 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -32.38% vs 12.43% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -29.28% vs -46.81% in Sep 2024
Quarterly - Interest
Interest 0.57 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -1.72% vs 9.43% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 46.15% vs 1,200.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.85%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
